CPT2 p.Arg503=
c.1509C>T · rs1572385867 · VCV796190
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -1.2 | GERP -4.3, phastCons 0.001 |
| Overall | ||
| CADD | 2.348 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CPT2
- Protein
- p.Arg503=
- Coding
- c.1509C>T
- MANE Select
- NM_000098
- dbSNP
- rs1572385867
- Type
- single nucleotide variant
- Location
- chr1:53211183 (GRCh38)
- Gene constraint
- LOEUF 1.038 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.52
- Residue 503
- a UniProt-annotated variant site (in cpt2d)
Disease context
encephalopathy, acute, infection-induced, susceptibility to, 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: carnitine palmitoyl transferase II deficiency, myopathic formcarnitine palmitoyl transferase II deficiency, severe infantile formcarnitine palmitoyl transferase II deficiency, neonatal formcarnitine palmitoyltransferase II deficiency
Similar variants
- CPT2 p.Arg503Cys Pathogenic/Likely pathogenic ★★ same residue
- CPT2 p.Arg503His Uncertain significance ★★ ⚠ same residue
- CPT2 c.340+1G>C Pathogenic/Likely pathogenic ★★ same condition
- CPT2 c.340+5G>A Likely pathogenic ★★ same condition
- CPT2 c.341-2A>G Pathogenic/Likely pathogenic ★★ same condition
- CPT2 p.Ala67Gly Likely pathogenic ★★ ⚠ same condition
- CPT2 p.Arg124Gln Likely pathogenic ★★ ⚠ same condition
- CPT2 p.Arg124Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cpt2-p-arg503 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown